Medien
Category: Nachrichten
Filtern nach
Besuchen Sie uns an unserem Stand N11, anlässlich der SSIEM 2023 in Jersualem, Israel
Visit us at our booth N11 at the SSIEM from 29.08.-01.09.2023 in Jerusalem, Israel, we are looking forward to meet you there.
Nachrichten
SAPROPTERIN DIPHARMA IST JETZT IN EUROPA UND DER SCHWEIZ ERHÄLTLICH
SAPROPTERIN DIPHARMA IS NOW AVAILABLE IN EUROPE AND SWITZERLAND Chiasso, Switzerland, July 3rd, 2023 – – Dipharma SA (“Dipharma”) today announced that its product Sapropterin Dipharma is now available in main European Countries and in Switzerland....
Dipharma und Logixx Pharma geben die Erteilung der Marktzulassung für generisches Sapropterin im Vereinigten Königreich bekannt
Chiasso, Switzerland and Reading, England, June 27, 2023 – Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”) are pleased to announce that the Medicines and Healthcare Products Regulatory Agency (“MHRA”) has granted Marketing Authorization for ...
Analog Pharma und Dipharma geben die Genehmigung der US FDA für einen abgekürzten Antrag auf ein neues Medikament (ANDA) für 20 mg generische Nitisinon-Kapseln (Temperaturstabil) bekannt.
Princeton, NJ and Chiasso, Switzerland, May 31st, 2023 | Analog Pharma (member of Duchesnay Pharmaceutical Group, hereafter “Analog”) and Dipharma S.A. (“Dipharma”) is pleased to announce that their 20 mg nitisinone abbreviated new drug applicatio...
Dipharma SA wird als eines der besten Unternehmen der Schweiz für 2022 ausgezeichnet
Chiasso, September 15th, 2022 | Dipharma SA, a specialty pharmaceutical company specialized in high quality and improved medicines for rare diseases, has been recently recognized as one of the best places to work for in Switzerland. During the ass...
Besuchen Sie unseren Stand im Rahmen der APS in Kassel
Visit us at our booth at the APS from 19.10.-21.10.2022 in Kassel, Germany, we are looking forward to meet you there.
Interview mit PharmaBoardRoom
Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen the largely unexplored rare diseases generics space and the opportunities in metabolic diseases. Marc-Olivier Geinoz – CEO, Dipharma SA Dipharma SA is a Swiss specialty pha...
